Microsoft, Amazon set to bid for $10B Pentagon cloud computing deal
By Akshay Kedari  Date: 2019-04-12

Microsoft, Amazon set to bid for $10B Pentagon cloud computing deal

The selection seemingly pushes IBM Corp and Oracle Corp outside the competition for the Defense Department’s contract

The U.S. Department of Defense has reportedly confirmed that Microsoft Corp and Amazon.com Inc have been chosen to compete for Pentagon cloud computing services as a part of a contract that could be worth around $10 billion.

Sources familiar with the matter informed that Microsoft and Amazon have been extensively viewed as leading candidates because they have gained higher-level of federal security clearances, besides meeting the minimum requirements for the Joint Enterprise Defense Infrastructure Cloud (JEDI) project.

The Joint Enterprise Defense Infrastructure cloud or JEDI is mainly used to serve as the primary data repository for the military services globally.

The selection seemingly pushes IBM Corp and Oracle Corp outside the competition for the contract for JEDI. Apparently, the contract is part of Pentagon’s efforts to broadly modernize its information technology systems.

Sources mentioned that Microsoft, Amazon Web Services, Oracle, and IBM were considered prime candidates for the contract. However, AWS at the time was the only sole company which was approved by the government to handle secret and top-secret data.

The Pentagon had initially mentioned that it would choose a winner this month but because of the size and complexity of the deal, an ongoing investigation, and potential protest litigation, the contract will likely be awarded in mid of July, a department spokeswoman, Elissa Smith said.

Sources further informed that Pentagon had disclosed in February it was assessing new information about possible conflicts of interest which are associated with the procurement that involved Deap Ubhi, a previous employee at a high-level Pentagon technology unit.

Smith also mentioned that the investigation of the department determined there is no unfavorable impact on the integrity of the acquisition process. Along with this, Pentagon will request the court to lift a stay in the case that it had asked to review the accusations.

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...